CSRS

Biomarker

1 paper3 findings

  • In silico1

Associations

3

Immune checkpoint inhibitors

upin silico1

1 study
  1. CSRS predicts immune checkpoint inhibitors in silico.

    “whereas the CSRS-low group showed an apparent better response to immune-checkpoint inhibitor therapy”

    In silicoin colon adenocarcinoma patients

    The Senescence-SASP Landscape in Colon Adenocarcinoma: Prognostic and Therapeutic Implications

    Current issues in molecular biology21 Jan 2026

More on Immune checkpoint inhibitors

Senescence-associated secretory phenotype (SASP)

upin silico1

1 study
  1. CSRS is associated with senescence-associated secretory phenotype (SASP) in silico.

    “The CSRS-high group exhibited significantly up-regulated senescence-associated secretory phenotype (SASP) and immune cell infiltration”

    In silicoin colon adenocarcinoma patients

    The Senescence-SASP Landscape in Colon Adenocarcinoma: Prognostic and Therapeutic Implications

    Current issues in molecular biology21 Jan 2026

More on Senescence-associated secretory phenotype (SASP)

Overall survival

downin silico1

1 study
  1. CSRS predicts overall survival in silico.

    “In a multivariate Cox proportional hazards model, the CSRS score, age and TNM stage were all identified as significant independent indicators for overall survival”

    In silicoin colon adenocarcinoma patients

    The Senescence-SASP Landscape in Colon Adenocarcinoma: Prognostic and Therapeutic Implications

    Current issues in molecular biology21 Jan 2026

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months